Glioma residual or recurrence versus radiation necrosis: Accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): Initial results

Journal of Neuro-Oncology

Volumn 106, Issue 3, 2012, Pages 579-587

  Amin, Amr ^a,b   Moustafa, Hosna ^a   Ahmed, Ebaa ^c   El Toukhy, Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Assuit University ^*  (Egypt)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

Glioma; Post radiation necrosis; Proton magnetic resonance spectroscopy; Tc 99m (V) DMSA brain SPECT

Indexed keywords

SUCCIMER TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOMA; HUMAN; INTERMETHOD COMPARISON; LESION TO NORMAL DELAYED UPTAKE RATIO; MALE; MINIMAL RESIDUAL DISEASE; NEUROIMAGING; NEUROPATHOLOGY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION NECROSIS; RADIOLOGICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

EID: 84857061523     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0694-2     Document Type: Article

References (60)

1. Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95: 1-11
2. Perry A, Schmidt RE (2006) Cancer therapy-associated CNS neuropathology: an update and review of the literature. Acta Neuropathol 111: 197-212
3. Hollingworth W, Medina LS, Lenkinski RE, Shibata DK, Bernal B, Zurakowski D, Comstock B, Jarvik JG (2006) A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumors. Am J Neuroradiol 27: 1404-1411 (Pubitemid 44260118)
4. Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F (2004) Evidence that 99mTc- (V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging 31: 77-84 (Pubitemid 38133544)
5. Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F (2005) Correlation between 99mTc- (V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging 32: 820-827 (Pubitemid 41125425)
6. Tsiouris S, Pirmettis I, Chatzipanagiotou T, Ptohis N, Papantoniou V (2007) Pentavalent technetium-99m dimercaptosuccinic acid 99mTc- (V) DMSA brain scintitomography a plausible noninvasive depicter of glioblastoma proliferation and therapy response. J Neurooncol 85: 291-295 (Pubitemid 350142519)
7. Barai S, Bandopadhayaya G, Julka P, Malhotra A, Naik K, Haloi A, Seith A, Halanaik D (2004) Imaging of recurrent brain tumors with trivalent (99m) Tc-dimercaptosuccinic acid-initial results. Hell J Nucl Med 7: 44-47 (Pubitemid 38679029)
8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109 (Pubitemid 47103521)
9. Hirano T, Tomiyoshi K, Zhang Ying Jian, Ishida T.Inoue T, Endo K (1994) Preparation and clinical evaluation of 99mTc-DMSA for tumor scintigraphy. Eur J Nucl Med 21: 82-85 (Pubitemid 24009666)
10. Henze M, Mohammed A, Schlemmer HP, Herfarth KK, Hoffner S, Haufe S, Mier W, Eisenhut M, Debus J, Haberkorn U (2004) PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating- characteristic analysis. J Nucl Med 45: 579-586 (Pubitemid 47618588)
11. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2: 494-503 (Pubitemid 44275725)
12. Central Brain Tumor Registry of the United States. http: //www. CBTRUS.org
13. Burton EC, Prados MD (2000) Malignant gliomas. Curr Treat Options Oncol 1: 459-468
14. Byrne TN (1994) Imaging of gliomas. Semin Oncol 21: 162-171 (Pubitemid 24125956)
15. Chen W (2007) Clinical applications of PET in brain tumors. J Nucl Med 48: 1468-1481 (Pubitemid 47397397)
16. Benard F, Romsa J, Hustinx R (2002) Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33: 148-162
17. Soler C, Beauchesne P, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, Brunon J (1998) Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25: 1649-1657 (Pubitemid 29008348)
18. Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K (1997) Technetium-99m (V)- DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. J Nucl Med 38: 1741-1749 (Pubitemid 27495522)
19. Goldman S (1996) Regional glucose metabolism and histopathology of gliomas: a study based on PET-guided stereotactic biopsy. Cancer 78: 1098-1106 (Pubitemid 26284876)
20. Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T, Ishikawa H, Hatakeyama R (1993) The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 20: 39-45 (Pubitemid 23015335)
21. Macapinlac H, Scott A, Caluser C et al (1992) Comparison of T1-201 and Tc-99m-2-methoxy isobutyl isonitrile (MIBI) with MRI in the evaluation of recurrent brain tumors. J Nucl Med 33: 867
22. Vos MJ, Tony BN, Hoekstra OS, Postma TJ, Heimans JJ, Hooft L (2007) Systematic review of the diagnostic accuracy of 201 Tl single photon emission computed tomography in the detection of recurrent glioma. Nucl Med Commun 28: 431-439 (Pubitemid 46684192)
23. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shidara N (1993) Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 7: 257-263 (Pubitemid 24012437)
24. Sasaki M, Ichiya Y, Kuwabara Y, Yoshida T, Inoue T, Morioka T, Hisada K, Fukui M, Masuda K (1996) Hyperperfusion and hypermetabolism in brain radiation necrosis with epileptic activity. J Nucl Med 37: 1174-1176 (Pubitemid 26329527)
25. Yoshii Y, Moritake T, Suzuki K, Fujita K, Nose T, Satou M (1996) Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT. ANJR Am J Neuroradiol 17: 1773-1776 (Pubitemid 26354789)
26. Le Jeune FP, Dubois F, Blond S, Steinling M (2006) Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies. J Neurooncol 77: 177-183 (Pubitemid 44419753)
27. Borodin OYU, Velichko OB, Garganeev AB et al (2000) Comparison of 99mTc-MIBI SPECT and GD-enhanced MRI in detection of recurrent tumor in malignant. Eur J Nucl Med 27: 154
28. Palumbo B, Lupattelli M, Pelliccioli GP, Chiarini P, Moschini TO, Palumbo I, Siepi D, Buoncristiani P, Nardi M, Giovenali P, Palumbo R (2006) Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy. Q J Nucl Med Mol Imaging 50: 88-93
29. Feun LG, Savaraj N, Landy HJ (1994) Drug resistance in brain tumors. J Neurooncol 20: 165-176 (Pubitemid 24309911)
30. Lehnert M (1994) Multidrug resistance in human cancer. J Neurooncol 22: 239-24331.
31. Andrews DW, Das R, Kim S, Zhang J, Curtis M (1994) Technetium- MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 40: 1323-1332
32. Ballinger JR, Sheldon KM, Boxen I, Erlichman C, Ling V (1995) Differences between accumulation of 99mTc-MIBI and 201Tlthallous chloride in tumour cells: role of P-glycoprotein. Q J Nucl Med 39: 122-128
33. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM (1993) Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53: 977-984 (Pubitemid 23087894)
34. Shibata Y, Matsumura A, Nose T (2002) Effect of expression of P-glycoprotein on technetium-99m methoxyisobutylisonitrile single photon emission computed tomography of brain tumors. Neurol Med Chir (Tokyo) 42: 325-330 (Pubitemid 34966445)
35. Hirano T, Otake H, Shibasaki T, Tamura M, Endo K (1997) Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA. J Nucl Med 38: 20-26 (Pubitemid 27026991)
36. Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BF, Feiden W, KirschCM (2002) Clinical value of iodine- 123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 20: 396-404 (Pubitemid 34072521)
37. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schäfers M, Palkovic S, Matheja P, Brandau W, Wassmann H, Schober O (1998) Diagnosis of recurrent glioma with SPECT and iodine- 123-alpha-methyl tyrosine. J Nucl Med 39: 23-27 (Pubitemid 28063167)
38. Kim EE, Chung SK, Haynie TP, Kim CG, Cho BJ, Podoloff DA, Tilbury RS, Yang DJ, Yung WK, Moser RP Jr, Ajani JA (1992) Differentiation of residual or recurrent tumors from post-treatment changes in F-18 FDG PET. Radiographics 12: 269-279
39. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK (1988) PET of malignant cerebral tumors after interstitial brachytherapy. demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 69: 830-838
40. Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon JE 2nd, Meisler WJ, Schold SC Jr (1991) Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol 29: 347-355
41. Ogawa T, Kanno I, Shishido F, Inugami A, Higano S, Fujita H, Murakami M, Uemura K, Yasui N, Mineura K et al (1991) Clinical value of PET with [18F]fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 32: 197-202
42. Ricci PE, Karis JP, Heiserman JE, Fram EK, Bice AN, Drayer BP (1998) Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? Am J Neuroradiol 19: 407-413 (Pubitemid 30422740)
43. Olivero WC, Dulebohn SC, Lister JR (1995) The use of PET in evaluating patients with primary brain tumors: is it useful? J Neurol Neurosurg Psychiatry 58: 250-252
44. Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N (2001) FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 42: 1551-1555 (Pubitemid 32953137)
45. Carvalho PA, Schwartz RB, Alexander E 3rd, Garada BM, Zimmerman RE, Loeffler JS, Holman BL (1992) Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77: 565-570
46. Byrne TN (1994) Imaging of gliomas. Semin Oncol 21: 162-171 (Pubitemid 24125956)
47. Leeds NE, Jackson EF (1994) Current imaging techniques for the evaluation of brain neoplasms. Curr Opin Oncol 6: 254-261 (Pubitemid 24146995)
48. 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas. J Neurooncol 46: 173-185 (Pubitemid 30352624)
49. Young RJ, Ghesani MV, Kagetsu NJ, Derogatis AJ (2005) Lesion size determines accuracy of thallium-201 brain single-photon emission tomography in differentiating between intracranial malignancy and infection in AIDS patients. Am J Neuroradiol 26: 1973-1979
50. Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T (2004) Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis. Neurosurgery 54: 1111-1117; discussion 1117-9
51. Chong VF, Rumpel H, Aw YS, Ho GL, Fan YF, Chua EJ (1999) Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. Int J Radiat Oncol Biol Phys 45: 699-705 (Pubitemid 29462652)
52. Schlemmer HP, Bachert P, Henze M, Buslei R, Herfarth KK, Debus J, van Kaick G (2002) Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 44: 216-222 (Pubitemid 36075911)
53. Schlemmer HP, Bachert P, Herfarth K, Zuna I, Debus J, van Kaick G (2001) Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy. Am J Neuroradiol 22: 1316-1324 (Pubitemid 32734804)
54. Chong VF, Rumpel H, Fan YF, Mukherji SK (2001) Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 11: 317-324 (Pubitemid 32755455)
55. Ando K, Ishikura R, Nagami Y, Morikawa T, Takada Y, Ikeda J, Nakao N, Matsumoto T, Arita N (2004) Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/ recurrent glioma from non-neoplastic lesions. Nippon Igaku Hoshasen Gakkai Zasshi 64: 121-126
56. 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 70: 49-58 (Pubitemid 39193997)
57. 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT. Rofo 176: 1114-1121 (Pubitemid 39118852)
58. Tzika AA, Zarifi MK, Goumnerova L, Astrakas LG, Zurakowski D, Young-Poussaint T, Anthony DC, Scott RM, Black PM (2002) Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging. Am J Neuroradiol 23: 322-333 (Pubitemid 34160445)
59. Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, Chang S, Prados MD, Sneed PK, Larson DA, Wara WM, McDermott M, Dillon WP, Gutin PH, Vigneron DB (1997) Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 87: 525-534 (Pubitemid 27430398)
60. McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, Dillon WP, Graves EE, Pirzkall A, Nelson SJ (2002) Histopathological validation of a threedimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97: 794-802 (Pubitemid 35222399)